European Medicines Agency (EMA) approved Moderna’s COVID-19 vaccine for children aged 12 to 17 years on Friday.
The drug regulator of European Union (EU) informed that a study conducted among 3,732 children aged 12 to 17 years found that a comparable antibody response was seen in young adults aged 18 to 25 years vis-à-vis the effects of Spikevax vaccine.
None of the 2,163 children who were injected the Spikevax vaccine got infected with COVID-19 compared with four out of 1,073 children administered placebo. The conclusion was that efficacy of Moderna’s vaccine in those aged 12 to 17 is similar to that in adults.
The common side-effects of Spikevax vaccine in children were same as those in adults — pain and swelling at the injection site, headache, nausea, vomiting and fever.
There will be two jabs of Spikevax vaccine in the muscles of upper arm, four weeks apart.
New Delhi: Maharashtra is all set for the state assembly elections on November 20. The…
Berhampur: Six persons, including two night watchmen and four sevayats, have been arrested for the…
Mumbai: Upholding a 10-year sentence for a man against whom his wife had lodged a…
New Delhi: Canada’s Peel Police on Thursday issued a statement clarifying the altercation between a…
Bhadrak: A dismembered body of a bank employee was found near Kednuapada railway station in…
Rourkale: Grocery and gift items worth lakhs were reduced to ashes in a massive fire,…
Malkangiri: A 12-year-old girl girl reportedly drowned in a pond during Boita Bandana ritual on…
New Delhi: President-elect Donald Trump on Friday announced that Robert F Kennedy Jr. would lead…